Efficacy and Safety Study of Vandetanib (ZD 6474) in Combination With Bicalutamide Versus Bicalutamide Alone in Patients With Chemotherapy Naive Hormone Refractory Prostate Cancer.

This study is currently recruiting participants.

Study NCT00757692 Information provided by British Columbia Cancer Agency

First Received: September 19, 2008 Last Updated: June 10, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	February 2010 (Final data collection date for primary outcome measure)